Welcome to our dedicated page for P3 HEALTH PARTNERS news (Ticker: PIII), a resource for investors and traders seeking the latest updates and insights on P3 HEALTH PARTNERS stock.
P3 Health Partners Inc (PIII) delivers physician-led population health management through integrated community care networks. This news hub provides investors and healthcare professionals with essential updates on the company's initiatives in value-based care models and patient-centered healthcare solutions.
Access real-time updates on earnings reports, strategic partnerships, and operational developments. Our curated collection features verified press releases and analysis of PIII's community health programs, care coordination advancements, and leadership in population health management.
Key coverage includes:
- Financial performance and market position updates
- Collaborative care network expansions
- Innovations in chronic disease management
- Physician engagement initiatives
- Value-based care model implementations
Bookmark this page for continuous access to PIII's latest developments in healthcare services. Monitor how their physician-led approach transforms community health outcomes through coordinated care strategies.
P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, has announced its participation in the 24th Annual Needham Virtual Healthcare Conference. The company's management team is scheduled to deliver a presentation on Thursday, April 10, 2025, at 9:45 AM Pacific Time.
Investors and interested parties can access the presentation through a webcast available on P3's Investor Relations Website at ir.p3hp.org. The presentation recording will remain accessible on the company's investor relations webpage for 30 days following the event.
P3 Health Partners (NASDAQ: PIII) reported its Q4 and full-year 2024 financial results, showing mixed performance. Full-year revenue reached $1.50 billion, up 18% year-over-year, with capitated revenue increasing 18% to $1.48 billion.
The company's at-risk membership grew 14% to 123,800 members. However, financial metrics showed significant challenges: Full-year net loss widened to $310.4 million from $186.4 million, while medical margin decreased 37% to $85.5 million. Q4 2024 results included total revenue of $370.7 million (up 7%) but showed a gross profit loss of $39.5 million.
CEO Aric Coffman highlighted the company's fundamentally strong business model and identified $130M+ in programmatic opportunities to improve financial sustainability.
P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, has announced it will release its fourth quarter and full year 2024 financial results on March 27, 2025. The company will host a conference call with management to discuss the results at 1:30 PM PT/4:30 PM ET on the same day.
P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, will participate in the TD Cowen 45th Annual Health Care Conference in Boston, Massachusetts.
Management is scheduled to host investor meetings on Wednesday, March 5th, 2025.
P3 Health Partners (NASDAQ: PIII) has announced preliminary guidance for 2025 and a proposed financing transaction. The company targets profitability in 2025 with projected revenues between $1.350 billion and $1.500 billion and Adjusted EBITDA ranging from negative $35 million to positive $5 million. CEO Aric Coffman noted that the company is on track with its $130+ million EBITDA growth initiatives and expects to issue full 2025 guidance with Q4 2024 earnings.
P3 is in discussions for a $30 million unsecured promissory note and warrants, similar to a December 2024 transaction. This financing is subject to approval by independent directors and final documentation. The guidance includes an estimated 108,000 to 118,000 at-risk members by the end of 2025. The company emphasizes that these projections are subject to change based on various factors, and no obligation to update estimates is assumed.
P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, will participate in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California. The company's management will deliver a presentation on Tuesday, January 14, 2024, at 7:30 AM Pacific Time. A webcast of the presentation will be accessible on P3’s Investor Relations Website at https://ir.p3hp.org/. Additionally, a replay of the presentation will be available on the same webpage for 30 days following the event.
P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, has announced its participation in the Noble Capital Markets 20th Annual Emerging Growth Equity Conference. The company's management will deliver a presentation on Tuesday, December 3, 2024, at 3:30 pm Eastern Time in Boca Raton, FL. Interested parties can access a live webcast of the presentation the following day through P3's Investor Relations Website at https://ir.p3hp.org/.
P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, has announced its participation in two upcoming investor conferences. The company will attend the 3rd Annual Needham Virtual Healthcare IT 1x1 Conference on Wednesday, November 20, 2024, and the BTIG Digital Health Forum on Monday, November 25, 2024.
P3 Health Partners (NASDAQ: PIII) announced its financial results for Q3 2024, ending September 30, 2024. Revenue increased by 26% YoY to $362.1 million. Capitated revenue rose by 25% to $357.7 million. However, the company reported a gross profit loss of $39.8 million, compared to a gross profit of $9.1 million in the previous year. The medical margin was $0.5 million, down from $36.2 million last year. Net loss widened to $102.9 million, up from $37.3 million. Adjusted EBITDA loss was $71.0 million, compared to $22.3 million in Q3 2023. Due to lower-than-expected risk adjustments and elevated medical costs, the company is withdrawing its previous FY 2024 guidance. Management will host a conference call on November 12, 2024, at 4:30 PM ET to discuss these results.
P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, has announced its upcoming third quarter 2024 financial results release and conference call. The company will release its Q3 2024 results and file its Quarterly Report on Form 10-Q on Tuesday, November 12, 2024. Management will host a conference call at 4:30 PM ET the same day to discuss the results. The call will be accessible via toll-free number 1-833-316-0546 (US) or international number 1-412-317-0692, and will also be webcast live on the company's investor website.
